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Abstract 
Background: The prevalence of Extended Spectrum Beta-Lactamases (ESBLs) production by uropathogenic bacteria have 
increased overtime raising a global concern in the therapeutic management of infections caused by these organisms. ESBLs 
contribute to multi drug resistance among the organisms and the detection of ESBLs is necessary in analyzing the 
antibiogram pattern of ESBLs producing isolates to enable better treatment. The aim of this study was to determine the 
prevalence of ESBL producers in pregnant women attending antenatal clinic at Saint Luke’s Hospital, Anua, Uyo, Nigeria. 
This is a well attended Urban Community Secondary Health facility providing antenatal care for pregnant women. 
 
Materials and Method: Three hundred and sixty five clean catch mid-stream urine specimens (n=365) were collected from 
pregnant women attending antenatal clinics at St Lukes Hospital, Anua, following an ethical approval by the relevant 
authorities. Identification of significant bacteriuria isolates was done using Microbact 24E (Oxoid, UK) system. The 
isolated bacteria were tested for their antibiotic susceptibility using Clinical laboratory standard institute (CLSI) 
recommended disc diffusion method. A double disk synergy test (DDST) was performed to determine ESBL production. 
 
Results:  The predominant bacterial pathogens were Escherichia. Coli (40%) followed by Klebsiella pneumonia (20%), 
Klebsiella oxytoca (11%), Citrobacter spp. (5%), Proteus mirabilis (1%), Enterobacter spp.(14%)  and Acinetobacter baumanii 
(9%). Sixteen (20%) out of the 80 uropathogenic isolates were found to be ESBL producers. Klebsiella pneumonia 8(50%) 
was the most prevalent ESBL producer. Other producers include Escherichia coli 6(38%), Klebsiella oxytoca 1(6%) and 
Enterobacter cloacae 1(6%).These ESBL producing isolates showed  resistance to Trimethoprim-sulphamethoxazole (100%), 
Ceftazidime (100%) and Cefotaxime (100%). They were however sensitive to Imipenem (100%), Azetronam (100%) and 
Ofloxacin (56%). Some these antimicrobials have restricted use during pregnancy.  
 
Conclusion: The prevalence of Community acquired Extended Spectrum beta lactamases (CA-ESBLs) causing 
asymptomatic bacteriuria during pregnancy is high in our locality and are probably the cause of multidrug resistance and 
treatment failures. 
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Contexte: La prévalence de spectre élargi Beta- Lactamases(BLSE) produisant par bactéries uropathogenes a augmenté au fil du 
temps soulevant une préoccupation mondiale dans la gestion thérapeutique des infections causées par ces organismes. BLSE 
contribuent a la multirésistance parmi les organismes et la détection de BLSE est nécessaire dans l'analyse du motif  
d'antibiogramme de BLSE qui produisent les isolats. Le but de cette recherche était déterminer la prévalence des producteurs de 
BLSE dans les femmes enceintes en consultation clinique prénatales a l'hôpital Saint Luke, Anua, Uyo, Nigeria -un centre de 




Matériels et méthode: Trois cent soixante cinq échantillons d'urine du milieu capture propres(n=365) ont été collectés des 
femmes enceintes en consultation cliniques prénatales a l'hôpital Saint Luke, Anua, suite a une approbation éthique par les 
autorités compétentes. L'identification des isolats de bactériurie significative ont été faits en utilisant le système Microbact 24E. 
Les bactéries isolées ont été testées pour leur sensibilité aux antibiotiques utilisant la méthode de diffusion de disque 
recommandée par Clinique institut standard de laboratoire  (CLSI). Un test de synergie double disque(DDST) a été effectué de 
déterminer la production de BLSE. 
 
Résultats: Les pathogènes bactériens étaient Escherichia coli (40%) suivi par Klebsiella pneumonia(20%), Klebsiella oxytoca(11%), 
Citrobacter spp.(5%), Proteus mirabilis (1%), Enterobacter spp.(14%) et Acinetobacter baumanii(9%). Seize (20%) sur les 80 isolats 
uropathogenes ont été trouvés d'etre producteurs de BLSE. Klebsiella pneumonia 8(50%) était le producteur de BLSE le plus 
prévalent. Les autres producteurs comprennent Escherichia coli 6 (38%), Klebsiella oxytoca 1 (6%) et Enterobacter cloacae 1(6%). 
Ces isolats de la production de BLSE ont montré une résistance aux Trimethroprime – sulphamethoxazole (100%), Ceftazidime 
(100%) and Cefotaxime (100%). Néanmoins, ils étaient sensibles aux Imipenem (100%), Azetronam (100%) Ofloxacin 
(56%).Certains de ces antimicrobiens ont l'usage restreint pendant la grossesse. 
 
Conclusion: La prévalence de Communautaire acquise spectre élargi des beta lactamases (CA - BLSE) provoquant bactériurie 
asymptomatique pendant la grossesse est élevée dans notre localité et sont probablement la cause de la multirésistance et les 
échecs de traitement. 
 




Urinary tract infections (UTIs) are caused by the 
presence and growth of micro-organisms in the 
urinary tract and are the single common bacterial 
infection of mankind (1).  In pregnancy, UTIs 
may involve the lower urinary tract or bladder 
(2). The three clinical manifestations of UTIs in 
pregnancy are asymptomatic bacteriuria, acute 
cystitis and pyelonephritis (3). Antibiotic 
resistance of urinary tract pathogens have been 
known to be on the increase worldwide 
especially to commonly used antimicrobials (4). 
Resistance to extended spectrum beta-lactams 
has been found among the strains of Klebsiella 
pneumonia and Escherichia coli isolates that 
produce Beta-lactamases which are resistant to 
penicillins, cephalosporins and 
monobactams(azetronam)(5).  
Beta-lactamases has been divided into four 
groups on the basis of substrate type and 
physical characteristics such as molecular weight 
and isoelectric point (5). Extended Spectrum Beta 
Lactamases is one of these groups and its 
appearance is due to consumption of third 
generation cephalosporins. Extended Spectrum 
Beta Lactamases was first reported in in early 
1980s in Europe and now they are being reported 
all over the world (5, 6). Extended Spectrum Beta 
Lactamases has variants of primary enzymes 
namely;TEM-1, TEM-2 and SHV-1.This variation 
is based on changes in one or more amino acids 
(5). 
In Nigeria, reports in literature have described 
the different epidemiological distributions of 
ESBL producing organisms. One study reported 
prevalence of 44.6% in Enugu State, another 
study reports a prevalence of 35% and an 
incidence of 9% in Nsukka (7, 8). Some other 
studies have also reported a prevalence of 72.5% 
in Lagos state and 15.4% in Kano State (9, 10). 
The paucity of such reports from the South – 
South region of Nigeria especially especially 
Akwa Ibom State necessitated this study. 
 
MATERIALS AND METHODS 
The study was carried out in a well attended 
secondary Health facility in Uyo, the capital of 
Akwa Ibom State located in the South-south 
region of Nigeria. All consenting pregnant 
women attending antenatal clinic at St Luke’s 
Hospital Anua, Uyo Akwa Ibom State and who 
are not on any antibiotics therapy during the 6 
months period of were included after obtaining 
ethical approval from the Research Ethics 
Committees of the Health care facilities. Three 
hundred and sixty five clean catch mid-stream 
urine specimens were collected and processed 
following standard procedure. Identification of 
bacterial isolates was carried out using Microbact 
24E (MB24E). Disc diffusion antibiotic 
susceptibility test was performed using the 
Kirby-Bauer method according to CLSI guideline 
using commercially available disc (Oxoid Ltd.) 
such as Ceftazidime (30ug), Cefotazime (30ug), 
Azetronam (30µg), Trimethoprim 
sulfamethoxazole (25µg), Imipenem (10 µg) and 
Ofloxacin (5 µg).  
All isolates that showed reduced susceptibility to 
3rd generation cephalosporins were screened for 
ESBL production using Double Disc Synergy 
Test Method (DDST).The test was carried out on 
Muller Hinton agar. A Muller Hinton agar was 
inoculated with a 0.5 McFarland turbidity of 
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presumptive bacteria. A Ceftazidime   30ug disc 
was placed on the plate 20mm (center to center) 
from Augumentin 30ug disk (amoxicillin and 
clavulanate 20ug/10ug). After   incubation for 
18- 24 hours at 37o C a clear extension of the edge 
of ceftazidime disc inhibition zone towards the 
disk containing clavulanate is described as 
synergy indicating the presence of an ESBL. 
 
RESULTS 
The 356 processed mid stream clean catch urine 
samples yielded 80 clinical isolates including 
Escherichia coli 32(40%) followed by Klebsiella 
pneumoniae16(20%), Citrobacter spp.4(5%), Proteus 
mirabilis 1(1%), Enterobacter spp.11(14%)  and 
Acinetobacter baumanii7(9%) were obtained (Table 
1). Out of the 80 clinical isolates that were 
screened for ESBL production, 20% was positive 
for ESBL production. These positive ESBL 
isolates were Klebsiella  pneumonia 8(50%), 
Escherichia coli 6(38%), Klebsiella oxytoca 1(6%) 
and Enterobacter cloacae 1(6%)(Table 2). 
The ESBL producing isolates showed 
resistance to Trimethoprim-sulphamethoxazole 
(100%), Ceftazidime (100%) and Cefotaxime 
(100%). They were however sensitive to 
Imipenem (100%), Azetronam (100%) and 












No.      (%) 
E. coli 32 (40) 
K. pneumoniae 16  (20) 
K. oxytoca 9   (11) 
C. sakazakii 2     (3) 
C. freundii 2     (2) 
P. mirabilis 1     (1) 
Enterobacter cloacae 11   (14) 
A. baumanii 7     (9) 
Total 80   (100) 
 
TABLE 2: ESBL PRODUCERS AMONG 
BACTERIAL ISOLATES 











6   (38) 
K. pneumoniae 8   (50) 
K. oxytoca 1    (6)  
C. sakazakii 0    (0) 
C. freundii 0    (0) 
P. mirabilis 0    (0) 
Enterobacter cloacae 1    (6) 
A. baumanii 0    (0) 






TABLE 3: ANTIBIOTIC SUSCEPTIBILITY PATTERN OF ESBL PRODUCING ISOLATES 
Antimicrobials             Antibiotic Susceptibility Pattern by the Isolates 
(µg)        E. coli ( n=6)    Klebsiella spp.( n=9) Enterobacter 
cloacae     ( n=1) 
S% R % S% R % S
% 
R % 





ATM (30) 6(100) 0 5(56) 4 (44) 0 1(100) 
SXT (25) 0 6 (100) 1(11) 8(89) 0 1(100) 
CTX (30) 0 6(100) 6 (67) 3(33) 0 1(100) 
OFX (5) 3(50) 3 (50) 5(56) 4(44) 0 1(100) 
CAZ (30) 0 6(100) 8(89) 1(11) 0 1(100) 




Although community acquired Extended 
Spectrum Beta Lactamase (CA-ESBL) - 
producing E. coli and K. pneumoniae has been 
reported both from Nigeria and other lands, the 
revelation from this study can be said to be of 
interest. Of note is the fact that while ESBL 
producing E. coli and Klebsiella species are mostly 
implicated in hospital acquired UTI, (11,12), they 
were found to be the major cause of ESBL UTI in 
the community, a trend that should be taken as 
dangerous. The overall prevalence of CA-ESBL 
UTI in this study was 20% while similar 
prevalence of 22% and 27.7% respectively has 
been reported by Agarawal (13) and   Esimone 
(14) as is also with other studies (15,16). 
Although these are higher than what this study 
revealed, increasing the sample size in 
furtherance to this study may reveal higher 
prevalence. This study also revealed that ESBL 





(100%), Cefotaxime (100%), and Ceftaxidime 
(100%), such resistance for ESBLs producing 
bacteria is often encoded on plasmids and can 
easily be transferred to other non-beta- lactams 
including fluroquinolones, aminoglycosides and 
cotrimoxazole (17). Obviously some of these 
drugs especially cephalosporins are safe in 
pregnancy but will not be effective if indicated. 
Carbapenems in this study and from other study 
are the drug of choice for infections caused by 
ESBLs producing gram negative bacteria (18,19). 
However, apart from being very expensive and 
not easily available in our environment, these 
drugs are not too safe during pregnancy. 
In conclusion: Although Uropathogens 
producing ESBLs are not routinely tested for in 
our locality, the prevalence of Community 
acquired Extended Spectrum beta lactamases 
(CA-ESBLs) causing asymptomatic bacteriuria 
during pregnancy is high and are probably the 
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